Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Upstream Bio Inc (NASDAQ: UPB) closed at $8.21 down -5.41% from its previous closing price of $8.68. In other words, the price has decreased by -$5.41 from its previous closing price. On the day, 0.91 million shares were traded.
Ratios:
For a deeper understanding of Upstream Bio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 44.63 and its Current Ratio is at 44.63. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On November 05, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $75.Piper Sandler initiated its Overweight rating on November 05, 2024, with a $75 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 15 ’24 when Chimovits Erez bought 825,000 shares for $17.00 per share. The transaction valued at 14,025,000 led to the insider holds 4,554,873 shares of the business.
ORBIMED ADVISORS LLC bought 825,000 shares of UPB for $14,025,000 on Oct 15 ’24. The Director now owns 4,554,873 shares after completing the transaction at $17.00 per share. On Oct 15 ’24, another insider, AI Upstream LLC, who serves as the 10% Owner of the company, bought 1,175,000 shares for $17.00 each. As a result, the insider paid 19,975,000 and bolstered with 1,175,000 shares of the company.
Stock Price History:
Over the past 52 weeks, UPB has reached a high of $29.46, while it has fallen to a 52-week low of $5.14. The 50-Day Moving Average of the stock is 2.33%, while the 200-Day Moving Average is calculated to be -42.74%.
Shares Statistics:
A total of 53.60M shares are outstanding, with a floating share count of 19.17M. Insiders hold about 64.29% of the company’s shares, while institutions hold 40.17% stake in the company.
Earnings Estimates
The stock of Upstream Bio Inc (UPB) is currently in the spotlight, with 3 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.68, with high estimates of -$0.65 and low estimates of -$0.7.
Analysts are recommending an EPS of between -$2.51 and -$2.61 for the fiscal current year, implying an average EPS of -$2.56. EPS for the following year is -$2.93, with 4.0 analysts recommending between -$2.76 and -$3.12.
Revenue Estimates
A total of 3 analysts have provided revenue estimates for UPB’s current fiscal year. The highest revenue estimate was $2.96M, while the lowest revenue estimate was $566k, resulting in an average revenue estimate of $1.97M. In the same quarter a year ago, actual revenue was $2.37M
